CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | ALTSHULER DAVID EVP, Chief Scientific Officer | Sale 10b5-1 | −1,272 | $480.00 | $611K | 32,974 |
| 2025-02-26 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Shares withheld for taxes | −4,962 | $479.61 | $2.4M | 54,969 |
| 2025-02-26 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Shares withheld for taxes 10b5-1 | −4,962 | $479.61 | $2.4M | 59,069 |
| 2025-02-26 | Sachdev Amit EVP Chief Patient & Ext Af Off | Shares withheld for taxes | −3,703 | $479.61 | $1.8M | 68,490 |
| 2025-02-26 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −14,079 | $479.61 | $6.8M | 105,915 |
| 2025-02-26 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −4,962 | $479.61 | $2.4M | 32,669 |
| 2025-02-26 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes 10b5-1 | −2,482 | $479.61 | $1.2M | 22,002 |
| 2025-02-26 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes | −7,071 | $479.61 | $3.4M | 62,935 |
| 2025-02-26 | Ambrose Kristen SVP & Chief Accounting Officer | Shares withheld for taxes | −1,241 | $479.61 | $595K | 7,845 |
| 2025-02-26 | ALTSHULER DAVID EVP, Chief Scientific Officer | Shares withheld for taxes 10b5-1 | −5,954 | $479.61 | $2.9M | 34,246 |
| 2025-02-25 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −354 | $480.95 | $170K | 64,031 |
| 2025-02-25 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Sale 10b5-1 | −1,767 | $480.95 | $850K | 24,484 |
| 2025-02-25 | Ambrose Kristen SVP & Chief Accounting Officer | Sale 10b5-1 | −884 | $480.95 | $425K | 9,086 |
| 2025-02-25 | ALTSHULER DAVID EVP, Chief Scientific Officer | Sale 10b5-1 | −848 | $480.95 | $408K | 40,200 |
| 2025-02-24 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Shares withheld for taxes | −3,310 | $483.28 | $1.6M | 59,931 |
| 2025-02-24 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Shares withheld for taxes 10b5-1 | −3,310 | $483.28 | $1.6M | 64,385 |
| 2025-02-24 | Sachdev Amit EVP Chief Patient & Ext Af Off | Shares withheld for taxes | −2,470 | $483.28 | $1.2M | 72,193 |
| 2025-02-24 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −9,386 | $483.28 | $4.5M | 119,994 |
| 2025-02-24 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −3,310 | $483.28 | $1.6M | 37,631 |
| 2025-02-24 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes 10b5-1 | −1,656 | $483.28 | $800K | 26,251 |
Page 14 of 18 · 344 trades